↓ Skip to main content

American College of Cardiology

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer

Overview of attention for article published in JACC: CardioOncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 472)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
161 X users
facebook
3 Facebook pages

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
118 Mendeley
Title
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
Published in
JACC: CardioOncology, September 2019
DOI 10.1016/j.jaccao.2019.08.003
Pubmed ID
Authors

Ariane V.S. Macedo, Ludhmila A. Hajjar, Alexander R. Lyon, Bruno R. Nascimento, Alessandro Putzu, Lorenzo Rossi, Rafael B. Costa, Giovanni Landoni, Angélica Nogueira-Rodrigues, Antonio L.P. Ribeiro

X Demographics

X Demographics

The data shown below were collected from the profiles of 161 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 118 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 14%
Student > Ph. D. Student 13 11%
Student > Bachelor 12 10%
Other 9 8%
Student > Postgraduate 9 8%
Other 23 19%
Unknown 35 30%
Readers by discipline Count As %
Medicine and Dentistry 51 43%
Biochemistry, Genetics and Molecular Biology 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Unspecified 2 2%
Nursing and Health Professions 2 2%
Other 9 8%
Unknown 39 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 96. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2023.
All research outputs
#449,254
of 25,743,152 outputs
Outputs from JACC: CardioOncology
#24
of 472 outputs
Outputs of similar age
#9,531
of 357,906 outputs
Outputs of similar age from JACC: CardioOncology
#3
of 16 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 472 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,906 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.